The role of targeted therapy and biomarkers in breast cancer treatment.
about
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: IV. Tissue collection, processing, and storage in endometriosis researchThe marine-derived sipholenol A-4-O-3',4'-dichlorobenzoate inhibits breast cancer growth and motility in vitro and in vivo through the suppression of Brk and FAK signaling.Biocompatible nanopolymers: the next generation of breast cancer treatment?Ganoderiol A-enriched extract suppresses migration and adhesion of MDA-MB-231 cells by inhibiting FAK-SRC-paxillin cascade pathway.Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.Huaier Extract Induces Autophagic Cell Death by Inhibiting the mTOR/S6K Pathway in Breast Cancer Cells.LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.The expression and clinical significance of HERC4 in breast cancer.Breast cancer causes and treatment: where are we going wrong?Clinical implications of high NQO1 expression in breast cancersSomatic alterations as the basis for resistance to targeted therapies.Survival prediction score: a simple but age-dependent method predicting prognosis in patients undergoing palliative radiotherapy.Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor.GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer.PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer.The role of the pathology department in the preanalytical phase of molecular analyses.Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.Glutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancer.
P2860
Q26827259-17764382-6D7C-49E4-A561-6FB310532F1FQ33575622-C81332BE-0932-489D-B5F0-6B0B3CD58D08Q33864065-B25315AA-C910-4FA5-895D-95A70C402DECQ35034732-7D82714A-90B4-4794-8425-49498C82A742Q35143022-39E52025-8EF7-46AA-84CF-87CC7A01D39AQ35680733-BC4C8110-8C2F-4222-80F4-98BA5C9F2E43Q36375254-5352452B-D33F-4E6A-988B-309AF46AC197Q37322118-EF5FC4BF-A4F0-408A-BFDC-2A8C154401B7Q37593526-C628791D-B33C-4780-871B-78FFDBABD9EAQ37621051-3AFEF063-4447-4826-A087-D9FF42BCF4E7Q38151570-ABFF64F4-3466-43A2-8BCA-ECD928A4114EQ38632096-C64B243C-93A6-4EFB-900A-B45DC2B732D5Q42457894-5058B6E9-2DCD-4A5F-9B3D-8EB250C27C2CQ47123679-7413C0FB-AEA3-44CF-8460-DF769EEB538BQ50523894-18C082D6-ED44-4C3D-A91F-CCA0178EF1D8Q52562703-8042A5BB-B279-48B2-8785-5872290A17C8Q53788180-3F8257C4-BA0D-4D49-8AEA-CD0D5ED72F0DQ54579368-85B16088-C237-4AA7-A996-823146A3351A
P2860
The role of targeted therapy and biomarkers in breast cancer treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The role of targeted therapy and biomarkers in breast cancer treatment.
@en
type
label
The role of targeted therapy and biomarkers in breast cancer treatment.
@en
prefLabel
The role of targeted therapy and biomarkers in breast cancer treatment.
@en
P2093
P2860
P1476
The role of targeted therapy and biomarkers in breast cancer treatment.
@en
P2093
Alison T Stopeck
Ben Ho Park
Clifford A Hudis
Hong Yuen Wong
Hope S Rugo
Sara E Barnato
Ursa Brown-Glaberman
William J Gradishar
P2860
P2888
P304
P356
10.1007/S10585-012-9496-Y
P577
2012-06-13T00:00:00Z
P6179
1040153979